The life sciences company provides an overview and update on its SweetBiotix® product range, a portfolio of natural, sweet, high fibre, low-calorie products developed to replace sugar and sugar substitutes.
The life sciences company has received its first order from a major weight management brand, reflecting growing interest in its appetite-reducing ingredients.
The healthcare company has announced a director has purchased additional shares in the business.
The life sciences company announces its Chief Executive Officer has purchased additional shares in the business.
The life sciences company reported a 102% increase in revenue and improved gross margins, despite ongoing operating losses. Expansion in key markets and new product launches signal potential future growth.
The life sciences company has been approved to trade on the OTCQB Venture Market in the US, aiming to increase its visibility and investor base in the country.
The life sciences company has signed a distribution agreement with a major weight management brand to sell its SlimBiome and WellBiome products under the partner's own branding.
The life sciences company has launched its appetite-reducing SlimBiome ingredient in a top-selling US weight loss supplement brand.
The life sciences company has issued options over new ordinary shares to a director.
The life sciences company reports strong growth in revenue, profit, and margins for the first half of 2025, driven by expansion into new markets and cost reductions.